3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
71
CNP Quote, Financials, Valuation and Earnings
Last price:
$36.22
Seasonality move
:
2.89%
Day range:
$36.08 - $36.97
52-week range:
$25.41 - $36.97
Dividend yield:
2.29%
P/E ratio:
22.79x
P/S ratio:
2.70x
P/B ratio:
2.22x
Volume:
9.3M
Avg. volume:
5.2M
1-year change:
27.17%
Market cap:
$23.6B
Revenue:
$8.6B
EPS (TTM):
$1.59
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.4B | $8.4B | $9.3B | $8.7B | $8.6B | |
| Revenue Growth (YoY) | -1.93% | 12.59% | 11.6% | -6.71% | -0.61% | |
| Cost of Revenues | $4.5B | $5.1B | $5.9B | $5B | $4.7B | |
| Gross Profit | $2.9B | $3.2B | $3.4B | $3.7B | $4B | |
| Gross Profit Margin | 39.49% | 38.4% | 36.45% | 42.39% | 46% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$132M | -$56M | $375M | $28M | $62M | |
| Operating Expenses | $1.7B | $1.8B | $1.8B | $1.9B | $2B | |
| Operating Income | $1.2B | $1.4B | $1.6B | $1.8B | $2B | |
| Net Interest Expenses | $529M | $529M | $524M | $701M | $838M | |
| EBT. Incl. Unusual Items | $563M | $778M | $1.4B | $1.1B | $1.2B | |
| Earnings of Discontinued Ops. | -$1.3B | $818M | -- | -- | -- | |
| Income Tax Expense | $80M | $110M | $360M | $170M | $195M | |
| Net Income to Company | -$773M | $1.5B | $1.1B | $917M | $1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$773M | $1.5B | $1.1B | $917M | $1B | |
| Basic EPS (Cont. Ops) | -$1.79 | $2.35 | $1.60 | $1.37 | $1.58 | |
| Diluted EPS (Cont. Ops) | -$1.79 | $2.28 | $1.59 | $1.37 | $1.58 | |
| Weighted Average Basic Share | $531M | $593M | $629.4M | $630.9M | $643.2M | |
| Weighted Average Diluted Share | $531M | $610M | $632.3M | $633.2M | $644.1M | |
| EBITDA | $2.3B | $2.6B | $3.2B | $3.2B | $3.5B | |
| EBIT | $1.1B | $1.3B | $1.9B | $1.8B | $2.1B | |
| Revenue (Reported) | $7.4B | $8.4B | $9.3B | $8.7B | $8.6B | |
| Operating Income (Reported) | $1.2B | $1.4B | $1.6B | $1.8B | $2B | |
| Operating Income (Adjusted) | $1.1B | $1.3B | $1.9B | $1.8B | $2.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.3B | $2.7B | $2.2B | $2.3B | |
| Revenue Growth (YoY) | 1.73% | 12.66% | 17.16% | -19.51% | 3.67% | |
| Cost of Revenues | $1.3B | $1.5B | $1.9B | $1.4B | $1.3B | |
| Gross Profit | $718M | $799M | $810M | $810M | $976M | |
| Gross Profit Margin | 34.96% | 34.53% | 29.88% | 37.12% | 43.15% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $17M | -$118M | -$50M | -$3M | $19M | |
| Operating Expenses | $433M | $463M | $456M | $489M | $493M | |
| Operating Income | $285M | $336M | $354M | $321M | $483M | |
| Net Interest Expenses | $119M | $133M | $138M | $201M | $222M | |
| EBT. Incl. Unusual Items | $183M | $85M | $166M | $117M | $280M | |
| Earnings of Discontinued Ops. | $64M | $616M | -- | -- | -- | |
| Income Tax Expense | $47M | $47M | $32M | -$75M | $32M | |
| Net Income to Company | $200M | $654M | $134M | $192M | $248M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $200M | $654M | $134M | $192M | $248M | |
| Basic EPS (Cont. Ops) | $0.28 | $1.06 | $0.19 | $0.30 | $0.38 | |
| Diluted EPS (Cont. Ops) | $0.27 | $1.03 | $0.19 | $0.30 | $0.38 | |
| Weighted Average Basic Share | $549M | $629M | $630.7M | $630.8M | $652.7M | |
| Weighted Average Diluted Share | $549M | $637M | $630.7M | $633.7M | $653.5M | |
| EBITDA | $606M | $547M | $618M | $677M | $858M | |
| EBIT | $302M | $218M | $304M | $318M | $502M | |
| Revenue (Reported) | $2.1B | $2.3B | $2.7B | $2.2B | $2.3B | |
| Operating Income (Reported) | $285M | $336M | $354M | $321M | $483M | |
| Operating Income (Adjusted) | $302M | $218M | $304M | $318M | $502M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.4B | $8.4B | $9.3B | $8.7B | $8.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.5B | $5.1B | $5.9B | $5B | $4.7B | |
| Gross Profit | $2.9B | $3.2B | $3.4B | $3.7B | $4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.6B | -$56M | $375M | $28M | $62M | |
| Operating Expenses | $1.7B | $1.8B | $1.8B | $1.9B | $2B | |
| Operating Income | $1.2B | $1.4B | $1.6B | $1.8B | $2B | |
| Net Interest Expenses | $529M | $529M | $524M | $701M | $838M | |
| EBT. Incl. Unusual Items | -$869M | $778M | $1.4B | $1.1B | $1.2B | |
| Earnings of Discontinued Ops. | -$190M | $818M | -- | -- | -- | |
| Income Tax Expense | -$286M | $110M | $360M | $170M | $195M | |
| Net Income to Company | -$773M | $1.5B | $1.1B | $917M | $1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$773M | $1.5B | $1.1B | $917M | $1B | |
| Basic EPS (Cont. Ops) | -$1.92 | $2.32 | $1.59 | $1.38 | $1.59 | |
| Diluted EPS (Cont. Ops) | -$1.93 | $2.28 | $1.59 | $1.36 | $1.59 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $850M | $2.6B | $3.2B | $3.2B | $3.5B | |
| EBIT | -$340M | $1.3B | $1.9B | $1.8B | $2.1B | |
| Revenue (Reported) | $7.4B | $8.4B | $9.3B | $8.7B | $8.6B | |
| Operating Income (Reported) | $1.2B | $1.4B | $1.6B | $1.8B | $2B | |
| Operating Income (Adjusted) | -$340M | $1.3B | $1.9B | $1.8B | $2.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.4B | $9.3B | $8.7B | $8.6B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $5.1B | $5.9B | $5B | $4.7B | -- | |
| Gross Profit | $3.2B | $3.4B | $3.7B | $4B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$56M | $375M | $28M | $62M | -- | |
| Operating Expenses | $1.8B | $1.8B | $1.9B | $2B | -- | |
| Operating Income | $1.4B | $1.6B | $1.8B | $2B | -- | |
| Net Interest Expenses | $529M | $524M | $701M | $838M | -- | |
| EBT. Incl. Unusual Items | $778M | $1.4B | $1.1B | $1.2B | -- | |
| Earnings of Discontinued Ops. | $818M | -- | -- | -- | -- | |
| Income Tax Expense | $110M | $360M | $170M | $195M | -- | |
| Net Income to Company | $1.5B | $1.1B | $917M | $1B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.5B | $1.1B | $917M | $1B | -- | |
| Basic EPS (Cont. Ops) | $2.32 | $1.59 | $1.38 | $1.59 | -- | |
| Diluted EPS (Cont. Ops) | $2.28 | $1.59 | $1.36 | $1.59 | -- | |
| Weighted Average Basic Share | $2.4B | $2.5B | $2.5B | $2.6B | -- | |
| Weighted Average Diluted Share | $2.5B | $2.5B | $2.5B | $2.6B | -- | |
| EBITDA | $2.6B | $3.2B | $3.2B | $3.5B | -- | |
| EBIT | $1.3B | $1.9B | $1.8B | $2.1B | -- | |
| Revenue (Reported) | $8.4B | $9.3B | $8.7B | $8.6B | -- | |
| Operating Income (Reported) | $1.4B | $1.6B | $1.8B | $2B | -- | |
| Operating Income (Adjusted) | $1.3B | $1.9B | $1.8B | $2.1B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $147M | $230M | $74M | $90M | $24M | |
| Short Term Investments | $871M | $1.4B | $510M | $541M | $561M | |
| Accounts Receivable, Net | $676M | $690M | $889M | $710M | $717M | |
| Inventory | $500M | $608M | $876M | $770M | $714M | |
| Prepaid Expenses | $121M | -- | -- | -- | -- | |
| Other Current Assets | $18M | $1.5B | $1.6B | $306M | $362M | |
| Total Current Assets | $2.9B | $7.4B | $4.7B | $3B | $4.4B | |
| Property Plant And Equipment | $22.4B | $23.5B | $27.1B | $29.9B | $32.1B | |
| Long-Term Investments | $363M | -- | -- | -- | -- | |
| Goodwill | $4.7B | $4.3B | $4.3B | $4.2B | $3.9B | |
| Other Intangibles | $50M | $44M | -- | -- | -- | |
| Other Long-Term Assets | $986M | $176M | $215M | $162M | $247M | |
| Total Assets | $33.5B | $37.7B | $38.5B | $39.7B | $43.8B | |
| Accounts Payable | $853M | $1.2B | $1.4B | $917M | $1.3B | |
| Accrued Expenses | $145M | $136M | $159M | $236M | $274M | |
| Current Portion Of Long-Term Debt | $1.9B | $545M | $2B | $1.1B | $566M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.4B | $1.8B | $1B | $1.1B | $1.3B | |
| Total Current Liabilities | $4.8B | $4.3B | $5.1B | $3.9B | $4B | |
| Long-Term Debt | $11.5B | $15.6B | $14.8B | $17.6B | $20.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $25.1B | $28.3B | $28.5B | $30B | $33.1B | |
| Common Stock | $2.4B | $799M | $799M | $6M | $6M | |
| Other Common Equity Adj | -$90M | -$64M | -$31M | -$35M | -$17M | |
| Common Equity | $6B | $8.6B | $9.3B | $9.7B | $10.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8.3B | $9.4B | $10B | $9.7B | $10.7B | |
| Total Liabilities and Equity | $33.5B | $37.7B | $38.5B | $39.7B | $43.8B | |
| Cash and Short Terms | $1B | $1.7B | $584M | $631M | $585M | |
| Total Debt | $13.4B | $16.1B | $16.9B | $18.6B | $21B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $147M | $230M | $74M | $90M | $24M | |
| Short Term Investments | $871M | $1.4B | $510M | $541M | $561M | |
| Accounts Receivable, Net | $676M | $690M | $889M | $710M | $717M | |
| Inventory | $500M | $608M | $876M | $770M | $714M | |
| Prepaid Expenses | $121M | -- | -- | -- | -- | |
| Other Current Assets | $18M | $1.5B | $1.6B | $306M | $362M | |
| Total Current Assets | $2.9B | $7.4B | $4.7B | $3B | $4.4B | |
| Property Plant And Equipment | $22.4B | $23.5B | $27.1B | $29.9B | $32.1B | |
| Long-Term Investments | $363M | -- | -- | -- | -- | |
| Goodwill | $4.7B | $4.3B | $4.3B | $4.2B | $3.9B | |
| Other Intangibles | $50M | $44M | -- | -- | -- | |
| Other Long-Term Assets | $986M | $176M | $215M | $162M | $247M | |
| Total Assets | $33.5B | $37.7B | $38.5B | $39.7B | $43.8B | |
| Accounts Payable | $853M | $1.2B | $1.4B | $917M | $1.3B | |
| Accrued Expenses | $145M | $136M | $159M | $236M | $274M | |
| Current Portion Of Long-Term Debt | $1.9B | $545M | $2B | $1.1B | $566M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.4B | $1.8B | $1B | $1.1B | $1.3B | |
| Total Current Liabilities | $4.8B | $4.3B | $5.1B | $3.9B | $4B | |
| Long-Term Debt | $11.5B | $15.6B | $14.8B | $17.6B | $20.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $25.1B | $28.3B | $28.5B | $30B | $33.1B | |
| Common Stock | $2.4B | $799M | $799M | $6M | $6M | |
| Other Common Equity Adj | -$90M | -$64M | -$31M | -$35M | -$17M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $8.3B | $9.4B | $10B | $9.7B | $10.7B | |
| Total Liabilities and Equity | $33.5B | $37.7B | $38.5B | $39.7B | $43.8B | |
| Cash and Short Terms | $1B | $1.7B | $584M | $631M | $585M | |
| Total Debt | $13.4B | $16.1B | $16.9B | $18.6B | $21B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$773M | $1.5B | $1.1B | $917M | $1B | |
| Depreciation & Amoritzation | $1.2B | $1.3B | $1.3B | $1.4B | $1.4B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $114M | -$17M | -$480M | $349M | -$111M | |
| Change in Inventories | $9M | -$140M | -$259M | $167M | $42M | |
| Cash From Operations | $2B | $22M | $1.8B | $3.9B | $2.1B | |
| Capital Expenditures | $2.6B | $3.2B | $4.4B | $4.4B | $4.5B | |
| Cash Acquisitions | $1.2B | $22M | $2.1B | $144M | -- | |
| Cash From Investing | -$1.3B | -$1.9B | -$1.6B | -$4.2B | -$4.5B | |
| Dividends Paid (Ex Special Dividend) | -$529M | -$492M | -$489M | -$535M | -$522M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.8B | $4.5B | $2.5B | $6B | $4B | |
| Long-Term Debt Repaid | -$3.5B | -$3.1B | -$2.4B | -$4.3B | -$1.6B | |
| Repurchase of Common Stock | -- | -- | -- | -$800M | -- | |
| Other Financing Activities | -$14M | -$43M | -$43M | -$80M | -$63M | |
| Cash From Financing | -$834M | $1.9B | -$345M | $374M | $2.3B | |
| Beginning Cash (CF) | $271M | $167M | $254M | $91M | $109M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$104M | $87M | -$163M | $18M | -$79M | |
| Ending Cash (CF) | $167M | $254M | $91M | $109M | $30M | |
| Levered Free Cash Flow | -$601M | -$3.1B | -$2.6B | -$524M | -$2.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $363M | $531M | $325M | $350M | -- | |
| Depreciation & Amoritzation | $307M | $318M | $319M | $363M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $32M | -$200M | $364M | -$38M | -- | |
| Change in Inventories | $99M | $132M | $95M | $93M | -- | |
| Cash From Operations | -$1.7B | $580M | $1.7B | $538M | -- | |
| Capital Expenditures | $594M | $846M | $1.1B | $845M | -- | |
| Cash Acquisitions | -- | $2.1B | -- | -- | -- | |
| Cash From Investing | -$604M | $1.9B | -$1.2B | -$844M | -- | |
| Dividends Paid (Ex Special Dividend) | -$136M | -$131M | -$144M | -$126M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.8B | $792M | $3B | $555M | -- | |
| Long-Term Debt Repaid | -$388M | -$3.3B | -$3.4B | -$26M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$24M | -$14M | -$39M | -$30M | -- | |
| Cash From Financing | $2.3B | -$2.6B | -$519M | $376M | -- | |
| Beginning Cash (CF) | $167M | $254M | $91M | $109M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$107M | $39M | $70M | -- | |
| Ending Cash (CF) | $167M | $147M | $130M | $179M | -- | |
| Levered Free Cash Flow | -$2.3B | -$266M | $590M | -$307M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$773M | $1.5B | $1.1B | $917M | $1B | |
| Depreciation & Amoritzation | $1.2B | $1.3B | $1.3B | $1.4B | $1.4B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $114M | -$17M | -$480M | $349M | -$111M | |
| Change in Inventories | $9M | -$140M | -$259M | $167M | $42M | |
| Cash From Operations | $2B | $22M | $1.8B | $3.9B | $2.1B | |
| Capital Expenditures | $2.6B | $3.2B | $4.4B | $4.4B | $4.5B | |
| Cash Acquisitions | $1.2B | $22M | $2.1B | $144M | -- | |
| Cash From Investing | -$1.3B | -$1.9B | -$1.6B | -$4.2B | -$4.5B | |
| Dividends Paid (Ex Special Dividend) | -$529M | -$492M | -$489M | -$535M | -$522M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.8B | $4.5B | $2.5B | $6B | $4B | |
| Long-Term Debt Repaid | -$3.5B | -$3.1B | -$2.4B | -$4.3B | -$1.6B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$14M | -$43M | -$43M | -$80M | -$63M | |
| Cash From Financing | -$834M | $1.9B | -$345M | $374M | $2.3B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$104M | -- | -$163M | $18M | -$79M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$601M | -$3.1B | -$2.6B | -$524M | -$2.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $363M | $531M | $325M | $350M | -- | |
| Depreciation & Amoritzation | $307M | $318M | $319M | $363M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $32M | -$200M | $364M | -$38M | -- | |
| Change in Inventories | $99M | $132M | $95M | $93M | -- | |
| Cash From Operations | -$1.7B | $580M | $1.7B | $538M | -- | |
| Capital Expenditures | $594M | $846M | $1.1B | $845M | -- | |
| Cash Acquisitions | -- | $2.1B | -- | -- | -- | |
| Cash From Investing | -$604M | $1.9B | -$1.2B | -$844M | -- | |
| Dividends Paid (Ex Special Dividend) | -$136M | -$131M | -$144M | -$126M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.8B | $792M | $3B | $555M | -- | |
| Long-Term Debt Repaid | -$388M | -$3.3B | -$3.4B | -$26M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$24M | -$14M | -$39M | -$30M | -- | |
| Cash From Financing | $2.3B | -$2.6B | -$519M | $376M | -- | |
| Beginning Cash (CF) | $167M | $254M | $91M | $109M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$107M | $39M | $70M | -- | |
| Ending Cash (CF) | $167M | $147M | $130M | $179M | -- | |
| Levered Free Cash Flow | -$2.3B | -$266M | $590M | -$307M | -- | |
Get CNP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNP
Sector
P/E ratio
22.79x
14.34x
PEG ratio
1.35x
0.47x
P/B ratio
2.22x
1.43x
Price / LTM sales
2.70x
1.57x
Growth Metrics
CNP
Sector
Revenue growth
3.67%
0.64%
Earnings growth
26.67%
-0.19%
Revenue (5-year growth)
2.7%
4.74%
Earnings forecast
$0.55
$0.66
Profitability
CNP
Sector
Profitability FY 2024
$4B
$1.4B
Return on invested capital
3.42%
3.42%
Return on assets
2.46%
2.49%
Return on equity
9.95%
7.96%
Earnings Date
Last Earnings Date
Feb
20
Next Earnings Date
Apr
30
Estimated Next Earnings Date
May
22
Balance Sheet
CNP
Sector
Total cash
$585M
$388.4M
Short term investments
$561M
$112.2M
Total assets
$43.8B
$12.1B
Long term debt
$21B
$4B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 15.72% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 2.73% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 4.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
